Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on World Wealth Journal.
Integra LifeSciences Reports Third Quarter 2025 Financial Results
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025. Third...
Captivision, Inc. Announces Additional Extension Granted by Nasdaq to Regain Compliance with Periodic Filing Requirement
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Captivision Inc. (“Captivision” or the “Company”) (NASDAQ: CAPT), a pioneering manufacturer and global LED solution provider, announced that it has been informed that the Nasdaq Hearings Panel (the “Panel”)...
JD.com to Report Third Quarter 2025 Financial Results on November 13, 2025
BEIJING, Oct. 30, 2025 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it plans to release its unaudited third...
Mutuum Finance (MUTM) Expands Over 17,600 Investors Base Ahead of V1 Lending Protocol Release
Dubai, UAE, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Interest in decentralized finance has surged again in 2025, with many investors now turning their focus toward Mutuum Finance (MUTM) — a new DeFi crypto project that’s building momentum ahead of its...
Experior Financial Group Wraps Up Second Year of Shine Commitment with Record $134,050 Donated in 2025
Experior concludes its year of support for Shine Foundation, to help make dreams come true for children and youth living with severe physical disabilities. GUELPH, ONTARIO, CANADA, October 30, 2025 /EINPresswire.com/ -- Experior Financial Group...
3D Systems Announces Date of Third Quarter 2025 Financial Results
ROCK HILL, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today it will release its financial results for the third quarter of 2025, ended September 30, 2025 after market close on Tuesday, November 4, 2025. The company...
InterDigital Announces Financial Results For Third Quarter 2025
New license agreements drive Revenue and EPS above increased outlook Annualized recurring revenue1 at all-time high of $588 million, up 49% YoY WILMINGTON, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video,...
Soybean Market Size Worth USD 310.07 Billion by 2034 | Towards FnB
Ottawa, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The global soybean market size stood at USD 199.66 billion in 2024 with projections indicating a rise from USD 208.64 billion in 2025 to reach USD 310.07 billion by 2034, according to a report published by...
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
REDWOOD CITY, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that its third quarter 2025 financial results will be released after market close on Thursday, November 6, 2025. Starting at 5:00 p.m....
Core Molding Technologies Reports Fiscal 2025 Third Quarter Results
2025 Full Year Sales Guidance Down 10% to 12% from Prior Year, and Well-Positioned to Accelerate 2026 New Program Launches COLUMBUS, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”,...
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior to market open. Management...
Scorpio Tankers Inc. Announces Financial Results for the Third Quarter of 2025 and an Increase to Its Quarterly Dividend
MONACO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Scorpio Tankers Inc. (NYSE: STNG) ("Scorpio Tankers" or the "Company") today reported its results for the three months ended September 30, 2025. The Company also announced that its board of directors (the...
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will...
Cork Celebrates Three Years of Keeping Small Businesses in Business - Merging Cyber Insight with Financial Resilience
Nearly four million compliance and risk events blocked for 38,800+ SMBs BOULDER, CO, UNITED STATES, October 30, 2025 /EINPresswire.com/ -- Cork Protection, a leading provider of risk insight platforms, marks its third anniversary this month,...
Freddie Mac Announces Third Quarter 2025 Financial Results
MCLEAN, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today reported its Third Quarter 2025 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company’s Form 10-Q...
FTC Solar to Announce Third Quarter 2025 Financial Results Wednesday, November 12, 2025
AUSTIN, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, today announced it will report its third quarter 2025 financial results before market...
Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights
CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the third quarter ended September 30, 2025, on Monday, November 10, 2025, prior to the open of...
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third quarter financial results on...
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will...
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Over 790,000 total VOQUEZNA® prescriptions filled to date Filled VOQUEZNA prescriptions increased 28% from Q2 2025 Net revenues of $49.5 million, up 25% quarter over quarter, and cash operating expenses down 43% quarter over quarter Full-year 2025...